STOCK TITAN

Cencora, Inc. - $COR STOCK NEWS

Welcome to our dedicated page for Cencora news (Ticker: $COR), a resource for investors and traders seeking the latest updates and insights on Cencora stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cencora's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cencora's position in the market.

Rhea-AI Summary
Cencora, Inc. (NYSE: COR) announces agreement to repurchase $250 million worth of common stock from Walgreens Boots Alliance Holdings LLC in concurrence with Rule 144 transactions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
buyback
-
Rhea-AI Summary
Walgreens Boots Alliance (WBA) announced the sale of shares of Cencora, Inc. (COR) through variable prepaid forward transactions, generating $424 million in current proceeds and potentially more at maturity. The company also conducted a concurrent share repurchase by Cencora for $250 million. The proceeds will be used for debt paydown and general corporate purposes, with no dilutive impact on adjusted EPS until the contracts mature in Q4 of fiscal year 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
Rhea-AI Summary
Cencora, Inc. (NYSE: COR) reported a 12.7% YoY increase in revenue to $68.9 billion for Q4 2023. For the fiscal year 2023, revenue increased 9.9% to $262.2 billion. GAAP diluted EPS for Q4 was $1.72, while adjusted diluted EPS was $2.86. For the fiscal year, GAAP diluted EPS was $8.53 and adjusted diluted EPS was $11.99.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.64%
Tags
Rhea-AI Summary
Cencora, Inc. (NYSE: COR) plans to release Q4 2023 results on November 2, 2023, before the opening of trading on NYSE. Conference call to discuss results at 8:30 a.m. ET. Webcast available on investor.cencora.com. Replays available via telephone and webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
-
Rhea-AI Summary
Cencora, Inc. completes name and stock ticker change, announces $5 million commitment to philanthropy
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
none
Cencora, Inc.

NYSE:COR

COR Rankings

COR Stock Data

44.80B
172.33M
13.5%
87.47%
4.07%
Drugs and Druggists' Sundries Merchant Wholesalers
Wholesale Trade
Link
United States of America
CONSHOHOCKEN

About COR

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.